Growth Metrics

Pfizer (PFE) Change in Acquisitions & Divestments (2016 - 2026)

Pfizer has reported Change in Acquisitions & Divestments over the past 17 years, most recently at $4.6 billion for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 15.7% to $4.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $18.6 billion through Mar 2026, up 123.94% year-over-year, with the annual reading at $18.0 billion for FY2025, 335.05% up from the prior year.
  • Change in Acquisitions & Divestments was $4.6 billion for Q1 2026 at Pfizer, down from $4.7 billion in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $35.1 billion in Q4 2022 and troughed at $658.0 million in Q1 2024.
  • The 5-year median for Change in Acquisitions & Divestments is $5.4 billion (2023), against an average of $8.1 billion.
  • Year-over-year, Change in Acquisitions & Divestments plummeted 89.72% in 2024 and then skyrocketed 520.97% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $35.1 billion in 2022, then tumbled by 39.45% to $21.2 billion in 2023, then tumbled by 87.62% to $2.6 billion in 2024, then skyrocketed by 79.58% to $4.7 billion in 2025, then dropped by 3.11% to $4.6 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Change in Acquisitions & Divestments are $4.6 billion (Q1 2026), $4.7 billion (Q4 2025), and $2.7 billion (Q3 2025).